Skip to content

IAS: Studies present reassuring data on the use of ART in patients on TB treatment

IAS: Botswanan study finds low concentrations of TB drugs common in HIV-positives, predict TB treatment failure

It’s time to integrate TB/HIV care on a national scale (part 1)

TB treatment and HBV: risk factors for liver toxicity in South Africans on antiretroviral therapy

HIV-positive patients may need longer duration of TB treatment

Decentralisation of care could improve adherence to TB treatment, Ethiopian study shows

CROI: Therapeutic concentrations of efavirenz, Kaletra, could be difficult to achieve in some children, with or without rifampicin

CROI: HIV treatment should not be delayed in TB patients with low CD4 counts, South African study shows

Risk of default on TB treatment halved by patient-centred adherence approach in Senegal study